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Abstract 
T cell immune responses are critical for protection of the host and for disease pathogenesis 
during infection with Plasmodium species.  We examined the regulation of CD4+ T cell 
cytokine responses during infection with Plasmodium berghei ANKA (PbA).  CD4+ T cells 
from PbA-infected mice produced IFN-, IL-4 and IL-10 in response to TCR stimulation at 
levels higher than those from uninfected mice.  This altered cytokine response was dependent 
on parasitemia.  To examine the specificity of the response, mice were adoptively transferred 
with CD4+ T cells from OT-II TCR transgenic mice, and were infected with PbA expressing 
OVA.   Unexpectedly, CD4+ T cells from the OT-II-transferred wild-type PbA-infected mice 
showed high levels of IFN- production after stimulation with OVA and the cells producing 
IFN- were not OT-II, but were host CD4+ T cells.  Further investigation revealed that host 
CD4+ T cells produced IFN- in response to IL-2 produced by activated OT-II cells.  This IFN- 
response was completely inhibited by anti-CD25 mAbs, and this effect was not due to the block 
of the survival signals provided by IL-2.  Furthermore, IFN- production by CD4+ T cells in 
response to PbA antigens was dependent on IL-2.  These findings suggest the importance of 
IL-2 levels during infection with malaria parasites and indicate that CD4+ T cells can produce 
IFN- without TCR engagement via a bystander mechanism in response to IL-2 produced by 
other activated CD4+ T cells. 
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Introduction 
Malaria is caused by infection of red blood cells with parasites of the Plasmodium species and 
remains one of the crucial threats to public health in the world.  The critical roles of cellular 
immunity in protection against the blood stage of malaria infection has been demonstrated in 
early studies using thymectomized rats and mice depleted of B cells by anti- chain Ab 
treatment (1-3).  These studies were confirmed using mice that were rendered B cell deficient 
by targeted disruption of Ig gene (4, 5).  It was also shown that protective immunity can be 
transferred to naïve hosts by adoptive transfer of immune CD4+ T cells (6).  IFN- produced by 
T cells as well as NK cells play a central role in regulating the protective immune response 
against blood-stage malaria infection (3,7-9).  Mice deficient in IFN- or its receptor showed 
delayed development of protective immunity and high mortality rate after infection with P. 
chabaudi (10).  However, as with other protective immunity, production of this potent cytokine 
is not always beneficial, but rather is harmful for the host in some cases.   Pregnant IFN--/- mice 
showed a delay in malaria-induced fetal loss relative to wild-type controls, although these mice 
experienced a more severe course of infection (11).  Neutralization of IFN- with its specific 
mAb early after infection with P. berghei ANKA (PbA) prevented cerebral malaria (12).  These 
studies point to the importance of regulation of IFN- levels during malaria infection in order to 
establish anti-parasite immune protection, while maintaining minimum pathogenesis.  However, 
little is known about the regulation of conventional CD4+ T cell function with respect to IFN- 
production during infection with Plasmodium species.   
 
We have examined the cytokine production of CD4+ T cells from mice infected with PbA. 
These T cells produced little IL-2 and a large amount of IFN-, IL-4 and IL-10 in response to 
TCR stimulation.  Further study indicated that the production of IFN- by CD4+ T cells from the 
infected mice does not necessarily require direct TCR engagement.  Rather, these CD4+ T cells 
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produced IFN-, IL-4 and IL-10 in response to IL-2.  Furthermore, IFN- production by CD4+ T 
cells in response to malaria-antigen was dependent on IL-2. 
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Methods 
 
Mice and P. berghei infection 
OT-II transgenic mice expressing the TCR specific for OVA323-339/I-Ab, were kindly provided 
by Dr. H. Kosaka (Osaka Univ., Japan) (13), B6.SJL-Ptprc congenic (B6.Ly5.1) mice 
(CD45.1+) by Dr. Y. Takahama (Tokushima Univ., Japan), Rag-2-/- mice by Dr. Y. Yoshikai 
(Kyushu University, Fukuoka, Japan) (14), MyD88-/- and TRIF-/- mice by Dr. K. Takeda and S. 
Akira (Osaka Univ., Japan) (15,16).  C57BL/6 (B6) mice were purchased from SLC 
(Hamamatsu, Japan).  OT-II and B6.Ly5.1 mice were bred and offspring were intercrossed to 
obtain CD45.1 OT-II mice.  Rag-2-/- mice and CD45.1 OT-II mice were intercrossed to obtain 
CD45.1 Rag-2-/- OT-II mice. These mice were maintained in the Laboratory Animal Center for 
Animal Research at Nagasaki University and were used at the age of 8-14 wks.  OVA-PbA was 
described previously (17).  Mice were infected with wild type PbA WT- or OVA-PbA by i.p. 
injection of parasitized RBCs (104 infected RBC),  monitored by microscopic examination of 
standard blood films and were sacrificed when parasitemia reached 3.7-15.0% (day 6-8).  The 
animal experiments reported herein were conducted according to the Guidelines of the 
Laboratory Animal Center for Biomedical Research at Nagasaki University. 
 
Adoptive transfer and flow cytometry 
For adoptive transfer, CD4+ T cells were purified using anti-CD4 IMag (BD Biosciences, San 
Diego, CA, USA), labeled with CFSE (Invitrogen, Carlsbad, CA, USA) at the final 
concentration of 15mM and were injected into the tail vein of B6.Ly5.1 or B6 mice (0.5-1 X 107 
/mice).  After infection with PbA and parasitemia reached 3%, spleen cells were prepared, 
stained with biotin-anti-CD45.2 plus streptavidin-Cy5.2 and PE-anti-CD4 mAb, and analyzed 
using FACScan (BD Biosciences) (Fig.3A).  For all other analysis, spleen cells were stained 
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with PE-Cy7-anti-CD45.1 (or anti-CD45.2), PE-Cy7- or allophycocyanin-anti-CD4, 
PE-anti-CD69, FITC- or PE-anti-CD25, FITC-streptavidin plus biotin-anti-CD122 or 
PE-anti-CD122, PE-anti-CD62L, FITC-anti-CD44, FITC-anti-TCR or 
allophycocyanin-streptavidin plus biotin-anti-NK1.1 mAb and analyzed using FACSCantoII 
(BD Biosciences).  For cell sorting, purified CD4+ T cells were stained with a combination of 
allophycocyanin-anti-CD4, FITC-anti-CD44, and PE-anti-CD62L (Fig. 2), or by a combination 
of PE-anti-CD4, PE-Cy7-anti-CD45.1 and allophycocyanin-anti-CD45.2 mAb (Fig. 4) and 
were sorted using FACSAria II (BD Biosciences).   
 
For intracellular cytokine staining, CD4+ T cells were stimulated with anti-TCR mAb (H57-597, 
10 g/ml), DC pulsed with OVA323-339 (10 g/ml) or recombinant IL-2 (10ng/ml) for total of 
12-24 h with an addition of monensin during the final 6 h.  After blocking Fc receptor with mAb 
(2.4G2), cells were stained with PE-Cy7-anti-CD45.1, allophycocyanin-anti-CD4, 
FITC-anti-CD44, FITC-anti-CD25, allophycocyanin- or FITC-streptavidin, biotin-anti-CD122, 
biotin-anti-NK1.1 or FITC-anti-TCR, fixed, permeabilized, and were stained with 
PE-anti-Foxp3, PE-anti-IL-2, PE-anti-IL-4, FITC- or PE-anti-IL-10, Alexaflour 488- or 
PE-anti-IFN- mAb according to the manufacturer’s instructions (BD Biosciences).  The ratios 
of viable cells were determined by staining cells with FITC-Annexin V and 
7-aminoactinomycin D (7AAD).   
 
Cell culture and ELISA 
CD4+ T cells (2-3X105) were cultured for 24-48 hr in 96-well plates coated with anti-TCR mAb 
(H57-597, 3-5 g/ml), or in the presence of recombinant IL-2 (10ng/ml), IL-7 (10ng/ml), IL-12 
(0.01-3ng/ml) (Pepro Tec, London, UK), or IL-18 (0.1-30ng/ml)(MBL, Nagoya, Japan).  For 
stimulation with protein antigens, CD4+ T cells (2-3X105) were cultured with DC (1-3X104) 
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pulsed with OVA323-339 (3 g/ml), streptococcal enterotoxin B (SEB, 2 g/ml)(Toxin Tec, 
Sarasota, FL, USA) or crude malaria Ag (6.6 x 107 RBCs/ml). Crude malaria antigens were 
prepared using blood samples collected from PbA-infected Rag2-/- mice (parasitemia ~45%). 
After washing, RBCs were suspended in PBS at a final concentration of 1 x 109 RBCs/ml, and 
were lysed by five freeze-thaw cycles as described previously (17).  DC (>95%) were prepared 
from B6 spleen cells using anti-CD11c MACS microbeads and autoMACS (Miltenyi Biotech, 
Gladbach, Germany).  IL-12 and IL-18 were neutralized using specific mAbs C17.8 (10 g/ml) 
and 93-10C (5 g/ml; MBL), respectively.  To prepare NK1.1-CD4+ T cells, splenocytes were 
depleted of NK1.1+ cells using autoMACS prior to CD4+ T cell purification.   
 
Transwell experiments were performed in 24-well plates with pore size 0.4 µM cell culture 
inserts (BD Biosciences).  OT-II CD4+ T-cells (2 x 105) were cultured in the bottom chamber in 
the presence and absence of DC (1x105) pulsed with OVA323-339 (3 g/ml).  Responder CD4+ 
T-cells (1.8 x 106) were cultured in the top chamber.  After 48 h in culture, supernatant was 
recovered from both upper and lower chambers.   
 
In the experiments using OT-II culture supernatant, OT-II CD4+ T cells (1x104) and DC (1x104) 
pulsed with OVA323-339 were cultured for 48 h in 96-well plate, and the supernatant was 
collected.  The level of IL-12 and IL-18 in the supernatant was 17.5 ± 2.3 pg/ml and 9.1±8.1 
pg/ml, respectively.  This supernatant (50 l) was added in culture (the total volume of 200l).  
Thus, the final concentration of IL-12 and IL-18 contained in the supernatant was ~4.4 pg/ml 
and ~2.3 pg/ml, respectively.  Inhibition of IL-2 receptor (CD25) was performed using a 
combination of 3C7 (5g/ml) and PC61.5 (5g/ml) (18,19). 
 
The levels of cytokines in the supernatants were determined by a sandwich ELISA according to 
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the manufacturer's directions using the following mAbs; JES6-1A12 and biotin-JES6-5H4 for 
IL-2, 11B11 and biotin-BVD6-24G2 for IL-4, and R4-6A2 and biotin-XMG1.2 for IFN-(all 
mAbs were from e-Bioscience, San Diego, CA, USA).  The levels of IL-10, IL-12p70 
(e-Bioscience), IL-18 (MBL) and TGF- (Promega, Madison, WI, USA) were determined 
using a manufacturer’s cytokine ELISA kits.   
 
Real-time RT-PCR 
The mRNA expression was determined by an automated real-time RT-PCR system using the 
ABI PRISM 7900HT Sequence Detection System (Applied Biosystems, Foster City, CA, USA) 
as described previously (20).  RNA was converted to cDNA and amplified by PCR in the PCR 
reaction buffer containing the dsDNA-specific fluorescent dye SYBR Green.  Sequences of 
primers used for IFN-, IL-4, T-bet, GATA3 and G3PDH are indicated (21-23).  Primers for 
IL-10 was 5'-TGACTGGCATGAGGATCAGC-3' and 5'-AGTCCGCAGCTCTAGGAGCA-3'.  
The mRNA levels were determined as the ratio of the each DNA to G3PDH. 
 
Statistical analysis 
Except for the frequency or count data, comparison of the distributions of measurements among 
groups was based on the logarithmic values of the measurements.  In comparison of two groups, 
t-test was used, while in comparison of three or more groups, overall comparison was first made 
by ANOVA (analysis of variance) for one-way or two-way data at the significance level of 0.05, 
and if significant, each pair of the groups was compared by t-test with the significance level 
determined by Bonferroni procedure controlling the familywise error rate (FEW) less than 0.05.  
Procedures of ANOVA and TTEST in the SAS○R  system were used for the calculations. 
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Results  
Up-regulation of cytokine production in CD4+ cells from PbA-infected mice  
To determine the function of CD4+ T cells during infection with malaria parasites, CD4+ cells 
from mice uninfected or infected with PbA were stimulated with DC pulsed with superantigen, 
SEB, or with plate-coated anti-TCR mAb (Fig. 1A).  CD4+ cells from PbA-infected mice 
showed increased production of IFN-, IL-4 and IL-10 in response to TCR stimulation, while 
the production of IL-2 was severely impaired.  The reduction in IL-2 production by T cells in 
infected mice was consistent with previous studies (24,25).  To examine whether the same cells 
produced IFN-, IL-4 and IL-10 simultaneously, we performed intracellular cytokine staining 
(Fig. 1B).  Approximately 50% of IL-10-producing cells produced IFN-, and ~80% of 
IL-4-producing cells produced IL-10, indicating that a significant number of cells produced 
multiple cytokines.  We focused further studies on the mechanism of upregulation of IFN-, 
IL-4 and IL-10 in PbA-infected mice.  These CD4+ cells expressed much higher levels of IFN-, 
IL-4 and IL-10 mRNA than those from naïve mice after anti-TCR-stimulation (Fig. 1C).  
However, these CD4+ cells did not express increased levels of T-bet or GATA-3 (Fig. 1C), key 
transcription factors of Th1 and Th2 differentiation (26), respectively, suggesting that the 
up-regulation of cytokine production was not due to the differentiation towards Th1 or Th2 
lineages.  Recently, it was shown that CD4+ T cells from post-septic model mice expressed a 
reduced level of IL-2 and increased levels of other cytokine genes including IFN-, IL-4 and 
IL-10 after stimulation with anti-CD3 mAb, and that they exhibited decreased capacity to 
commit to either Th1 or Th2 lineages (27).  Thus, this type of altered cytokine responses is not 
unique to PbA infection. 
 
Next, C57BL/6 mice were infected with PbA for 0-8 days, and the levels of parasitemia as well 
as cytokine production by CD4+ cells in response to anti-TCR mAb were monitored in 
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individual mice (Fig. 2A).  Parasitemia became detectable (~0.1%) 4 days after infection.  After 
5 days, when the level of parasitemia reached ~1%, the production of IFN- was greatly 
up-regulated.  However, after 3 days of chloroquine treatment, parasitemia became 
undetectable and IFN- production by CD4+ cells was reduced (Fig. 2B), indicating that the 
altered cytokine response by CD4+ cells was dependent on parasitemia.  We next examined 
whether IFN- producing cells were naïve or effector/memory (E/M) cells.  The proportion of 
E/M-type cells (CD62LlowCD44high) increased in CD4+ cells of PbA-infected mice (42.8%) 
when compared with those from uninfected mice (20.7%) (Fig. 2C).  Naïve 
(CD62LhighCD44low) and E/M-type cells were purified by cell sorting and were evaluated for 
their IFN--production.  E/M-type CD4+ T cells from PbA-infected mice produced IFN- at 
levels much higher than those from uninfected mice or naïve CD4+ T cells in response to 
anti-TCR mAb.    
 
Antigen specificity of CD4+ cells producing high levels of IFN-  
To determine whether the PbA-specific CD4+ T cells mediated high IFN- production, we used 
recombinant PbA that express OVA (OVA-PbA) (17).  C57BL/6 mice were adoptively 
transferred with CFSE-labeled CD4+ cells from OVA-specific TCR transgenic mice, OT-II, and 
were infected with wild type PbA (WT-PbA) or OVA-PbA (Fig. 3).  The proportion of OT-II 
cells was increased in mice infected with OVA-PbA (2.1%) when compared with mice not 
infected (0.3%) or infected with WT-PbA (0.4%).  OT-II cells divided 2-3 times and 
up-regulated activation markers CD69 and CD25 in the OVA-PbA-infected host (Fig. 3B), 
suggesting the specific activation of OT-II cells in response to OVA-PbA. However, total CD4+ 
cell population from mice infected with either WT- or OVA-PbA produced IFN- at levels much 
higher than those from uninfected mice after co-culture with DC pulsed with OVA323-339 (Fig. 
3C).  Intracellular cytokine staining showed that significant numbers of host CD4+ cells, and 
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not OT-II cells, produced IFN- in response to OVA323-339-pulsed DC (Fig. 3D).  To confirm 
this observation, OT-II and host CD4+ cells were purified by sorting, and examined for 
production of IFN- in response to OVA323-339-pulsed DC (Fig. 4).  Host CD4+ cells from 
infected mice did not produce significant levels of IFN-by themselves, indicating that these 
cells did not directly respond to OVA323-339.  When they were mixed with OT-II cells either 
from infected or uninfected mice, high levels of IFN- were detected, suggesting that CD4+ 
cells from infected mice produced IFN- in cooperation with activated OT-II cells.   
 
CD4+ cells from PbA-infected mice produce high levels of IFN-in response to a soluble 
mediator produced by OT-II 
To determine whether IFN- response of CD4+ cells from PbA-infected mice was mediated by 
the cognate interaction with OT-II or by soluble factor(s), two methods were used; transwell 
culture and the addition of culture supernatant.  When CD4+ cells from PbA-infected mice were 
cultured in the upper chamber and OT-II/OVA323-339-pulsed DC in the lower chamber, CD4+ 
cells produced IFN-at levels similar to co-culture (Fig. 5A).  Reproducible results were 
observed when the cells in upper and lower chambers were exchanged (data not shown). 
Culture supernatant from OT-II/OVA323-339-pulsed DC stimulated IFN- production by CD4+ T 
cells from PbA-infected mice (Fig. 5B).  These results suggest that CD4+ cells from 
PbA-infected mice produced IFN-without direct TCR engagement, and that this response was 
mediated by soluble factor(s) produced by OT-II/OVA323-339-pulsed DC.   
 
The major cytokines that are known to promote CD4+ T cell production of IFN- are IL-12 and 
IL-18 (28, 29).  A combination of these two cytokines can stimulate IFN- production of CD4+ 
T cells without TCR engagement (30-32).  Although these cytokines were able to stimulate 
IFN- production of CD4+ cells from PbA-infected mice (Fig. 6), the levels of IL-12 and IL-18 
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detected in the culture supernatant of the OT-II/OVA323-339-pulsed DC was 17.5 pg/ml and 9.1 
pg/ml, respectively, and was not sufficient to promote IFN- production (Fig. 6A, B).  In 
addition, a saturating concentration of anti-IL-12 mAb did not inhibit IFN- production by 
CD4+ cells co-cultured with OT-II/OVA323-339-pulsed DC or with their supernatant.  Since 
signal transduction through the IL-18 receptor depends on MyD88, the response of CD4+ cells 
from MyD88 KO mice were also examined.  CD4+ cells of the PbA-infected MyD88/Trif 
double KO mice produced IFN- at levels similar to CD4+ cells from PbA-infected B6 mice in 
the presence of culture supernatant from OT-II/OVA323-339-pulsed DC.  Saturating 
concentrations of anti-IL-12 and anti-IL-18 mAb did not have significant inhibitory effects (Fig. 
6).  Thus, the soluble mediator produced by OT-II/OVA323-339-pulsed DC, which stimulated 
IFN- production by CD4+ cells, was neither IL-12 nor IL-18. 
 
IL-2 stimulates IFN- production of CD4+ cells from PbA-infected mice 
Our study using different types of TCR transgenic T cells suggested that CD4+ T cells, and not 
CD8+ T cells, produced the stimulating factor (data not shown).   Therefore, we examined 
whether IL-2 can stimulate IFN- production.  OT-II cells produced IL-2 at a concentration of 
9.76 ± 1.26 ng/ml in the supernatant.  This concentration was sufficient to induce the 
production of IFN-, IL-4 and IL-10 in CD4+ cells from PbA-infected mice without TCR 
engagement, and the response was IL-2-dose dependent (Fig. 7, AB).  To confirm the effect of 
IL-2 on cytokine production, we used cocktails of anti-CD25 mAbs to inhibit IL-2 receptor 
signaling, and supplemented the culture with IL-7, which supported the survival of CD4+ T 
cells in the absence of IL-2 signals.  Anti-CD25 mAbs completely inhibited the production of 
IFN- by CD4+ cells from PbA-infected mice in response to the supernatant of OT-II cells or 
during co-culture with OT-II/OVA323-339-pulsed DC, and this effect was not due to the 
inhibition of survival signal, since the viability of CD4+ cells was not impaired (Fig. 7B).  Other 
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common -chain family cytokines such as IL-4, IL-7 and IL-15 did not have this effect (data not 
shown).  Therefore, we concluded that IL-2 produced by OT-II cells was responsible for IFN- 
production by CD4+ cells from PbA-infected mice.   
 
We examined the expression of the IL-2 receptor on CD4+ spleen cells.  Purified CD4+ cell 
population contained minor population of NK1.1+TCR+ NKT cells (4.9%) and NK1.1-TCR+ 
conventional T cells (92.2 %)(Fig. 8A).  The proportion of NKT cells was increased to 9.2% in 
CD4+ cells after infection with PbA.  In uninfected mice, 8.5% and 5.6% of CD4+ T 
(CD4+NK1.1-) cells expressed IL-2 receptor - and -chains, respectively.  These levels 
increased in PbA-infected mice to 24.0% and 17.3%, respectively.  Similarly, the expression of 
IL-2 receptor - and -chains increased in CD4+ NKT (CD4+NK1.1+) cells from 16.5% to 
28.8% and from 18.0% to 30.6% in PbA-infected mice, respectively.  The majority of 
CD4+CD25+ cells in uninfected mice were foxp3+ regulatory T cells, and this population did not 
increase in PbA-infected mice, while the proportion of CD25+foxp3-CD4+ T cells increased by 
~6.5 % (Fig. 8B).  These CD4+ cells were cultured in the presence of IL-2 for 24 h and IFN- 
expression was examined by intracellular cytokine staining (Fig 8C).  Despite their expression 
of IL-2 receptor, significant numbers of CD4+ T cells and NKT cells that produce IFN- were 
not detected in uninfected mice, indicating that CD4+foxp3+ cells did not produce IFN- in 
response to IL-2.  In contract, 4.8% and 10.4% of CD4+ T and NKT cells from PbA-infected 
mice, respectively, produced IFN- in response to IL-2.  Since the majority of CD4+ cells are 
NK1.1- conventional T cells, these cells are the main population of CD4+ cells that produce 
IFN- in response to IL-2.  Taken together, CD4+foxp3- conventional T cells, which were 
activated and expressed IL-2 receptor during Plasmodium-infection, produced IFN- in 
response to IL-2.   In addition, we were able to show that CD4+ NK T cells in PbA-infected 
mice also produced IFN- in response to IL-2. 
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Finally, we examined whether IFN- production by CD4+ T cells in response to TCR ligand, 
was dependent on IL-2 (Fig. 9).  CD4+ T cells (CD4+NK1.1- cells) were purified from mice 
before and after infection with PbA.  IFN- production by these CD4+ T cells was examined in 
the presence and absence of anti-CD25 mAbs and IL-7, which supported the survival.  CD4+ T 
cells from uninfected mice produced IFN- in response to anti-TCR mAb, although the level 
was lower than that of infected mice.  This response was almost completely inhibited by 
anti-CD25 mAbs.  CD4+ T cells from PbA-infected mice produced IFN- in response to PbA 
antigen, and this response was also inhibited by anti-CD25 mAbs.  The inhibitory effects of 
anti-CD25 mAbs were not due to the inhibition of survival singal, as shown previously (Fig. 
7B).  In contrast, IFN- production of the same CD4+ T cells in response to anti-TCR mAb was 
not inhibited by anti-CD25 mAbs.  Thus, CD4+ T cells from PbA-infected mice produced IFN- 
in IL-2-dependent in response to malaria antigens.  However, these CD4+ T cells produced 
IFN- in IL-2-independent manner in response to anti-TCR mAb.   
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Discussion 
CD4+ T cells of E/M phenotype produced high levels of IFN-, IL-4 and IL-10 in response to 
TCR occupancy during infection with PbA.  Using adoptive transfer of OT-II cells, we 
unexpectedly found that CD4+ T cells from PbA-infected mice, not OT-II cells, produced high 
levels of IFN- in response to OVA323-339-pulsed DC.  Further investigation revealed that CD4+ 
T cells from PbA-infected mice produced IFN-, IL-4 and IL-10 in response to IL-2 without 
TCR occupancy (Fig. 10).  To our knowledge, this is the first report that IL-2 can stimulate the 
production of IFN- by conventional T cells.  The IL-2 receptor is expressed on two types of 
CD4+ T cells, recently activated CD4+ cells and foxp3+ regulatory T cells.   It is likely that CD4+ 
T cells that were activated and induced to express IL-2 receptor by malaria antigens during 
infection produced IFN- in response to IL-2 in vitro, since ligation of the IL-2 receptor 
expressed on CD4+foxp3+ T cells of uninfected mice did not induce IFN- production.  IL-2 
receptor expression in conventional CD4+ T cells, however, is not sufficient for IL-2-dependent 
IFN- production.  CD4+CD25+foxp3- T cells that were pre-activated in vitro with anti-TCR 
mAb to induce the expression of IL-2 receptor did not produce IFN- in response to IL-2, 
consistent with previous studies (data not shown) (33).  It is intriguing that some cells produce 
IFN- in response to IL-2 and others do not.  One possibility is that CD4+ T cells have different 
components of the IL-2 receptor -, - and -chains forming high and intermediate affinity 
receptors, in which some of the -chains (CD25) are located in microdomains of the plasma 
membrane (34).  Signaling events induced by IL-2 may vary depending on the structure of the 
IL-2 receptor as well as association with other components such as lipid rafts (35).   
Alternatively, the signaling module of CD4+ T cells may vary between types of T cells and may 
depend on the nature of stimulation.   For example, IL-12 and IL-18 induce GADD45, an 
activator of MEKK4, which leads to p38 MAPK activation (32). In combination with other 
signaling pathways, the activation of this GADD45-MEKK4-p38 MAPK pathway leads to 
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IFN- production in CD4+ T cells without TCR engagement (30-32).   Further study is required 
to investigate the expression of GADD45 or other signaling molecules in the IFN- activation 
pathway by CD4+ T cells from PbA-infected mice. 
 
In addition to CD4+ T cells, we have shown that CD4+ NKT cells from PbA-infected mice also 
produced IFN- in response to IL-2.  It was previously reported that IL-2 induces IFN- 
production by human NK cells, V9V2 T cells and NKT cells (33,36).    In these studies, 
human cells were purified and stimulated in vitro with their appropriate ligands to induce 
expression of CD25.  Unlike typical IL-2 signaling pathway, the addition of IL-2 activated not 
only Stat3 and Stat5 pathways, but also Stat4 leading to the induction of IFN- production in 
NK, V9V2 T and NKT cells.  NK cells are important sources of IFN- during early response 
to Plasmodium infection (7).  In human studies, it was shown that NK cells from malaria-naïve 
donors produced IFN- in response to P. falciparum-infected RBCs in vitro (37).  Recently, it 
was shown that this NK response is dependent on IL-2 produced by CD4+ T cells (38).  In this 
study, we have shown that mouse CD4+ T and NKT cells are able to produce IFN- in response 
to IL-2 under certain conditions.  It will be intriguing to investigate whether CD4+ T cells from 
PbA-infected mice utilize signaling pathway similar to human NK, V9V2 T and NKT cells 
(33,36) in producing IFN- in response to IL-2.   
 
We have also shown that production of IFN- by CD4+ T cells from the infected mice in 
response to PbA was almost completely inhibited by anti-CD25 mAbs, indicating that these 
PbA-specific T cells produced IFN- in an IL-2 dependent manner.  The effect of anti-CD25 
mAbs as not due to the inhibition of survival signal, since the culture was supplemented with 
IL-7, and we did not detect any significant differences between CD4+ T cells culture with and 
without anti-CD25 mAbs.  Interestingly, CD4+ T cells showed differential dependencies on 
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IL-2 when stimulated with anti-TCR mAb.  IFN- production by CD4+ T cells in response to 
anti-TCR mAb was IL-2 prior to PbA-infection, but was IL-2 dependent during infection.  Thus, 
the IL-2-dependency of the IFN- response by CD4+ T cells varied depending on the source of 
T cells as well as the nature of the TCR ligand.   It is possible that the requirement of IL-2 for 
IFN- production differs between T cell types; effector CD4+ T cells that were induced during 
the active infection produce IFN- in an IL-2 independent manner, while naïve or memory 
CD4+ T cells produce IFN- in an IL-2 dependent manner.  Alternatively, the in vivo 
environment may influence the IL-2-dependency of CD4+ T cell response.  During 
PbA-infection, innate immune responses are activated which produce a variety of cytokines.  
This inflammatory environment may compensate for the IL-2 requirement and condition the 
IFN- response of T cells.    
 
IFN- plays important roles in regulating the protective immune response against blood-stage 
malaria infection and in the pathogenesis of cerebral malaria (3,39).  The data presented here 
indicate that the level of IFN- production by CD4+ T cells is critically dependent on the level of 
IL-2 production during infection with malaria parasites.  However, we and others have shown 
that the production of IL-2 in response to TCR occupancy was severely impaired in CD4+ T 
cells in mice infected with PbA and in patients with acute P. falciparum infection in Thailand 
(this study, 24,25).  While molecular mechanisms underlying the reduction in IL-2 production 
are not clearly understood, regulation of the levels of IFN- production during severe malaria 
infection may be important to reduce the pathogenesis caused by excessive IFN-.  Regulation 
of IFN- may also be beneficial for the parasite, since it can escape immune attack by activated 
immune effector mechanisms, including macrophages.  In fact, it is reported that treatment of P. 
yoelii infected mice with exogenous IL-2 restored IFN- and other cytokine expression and was 
associated with diminution of parasitemia, although the survival rate did not improve in this 
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study (40).  Finally, it is likely that this type of IL-2-dependency of IFN- production is also 
induced during infection with P. falciparum, the human malaria parasite, as well as in other 
infectious diseases or immune disorders.  Increased understanding of the molecular 
mechanisms underlying regulation of the cytokine network during infection should suggest 
methods to prevent the pathogenesis of malaria infection as well as other immune disorders and 
also enhance the protective immune response. 
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Abbreviations:  
PbA, Plasmodium berghei ANKA;  
OVA-PbA, Plasmodium berghei ANKA that expresses OVA;  
WT-PbA, Wild type Plasmodium berghei ANKA;  
SEB, streptococcal enterotoxin B;  
E/M, effector/memory 
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CD4+ T cells from PbA-infected mice produce high levels of IFN-, IL-4 and IL-10 in response 
to TCR stimulation.   
(A) CD4+ T cells from mice not infected or infected with PbA for 7 days (parasitemia 
6.4-7.8 %) were cultured in the presence of DC (1x104) pulsed with SEB or on plates coated 
with anti-TCR mAb.  The levels of IL-2, IFN-, IL-4, IL-10, and TGF- in the supernatant were 
determined by ELISA.  A significant difference was observed for all parameters between 
uninfected and infected mice (p < 0.005).  Representative data of 2 similar results are shown.  
(B) CD4+ T cells from mice not infected or infected with PbA for 6 days (parasitemia 
5.1-8.0 %) were stimulated with plate-coated anti-TCR mAb for 12 h and the expression of IL-2, 
IFN-IL-4, and IL-10 was determined by intracellular cytokine staining.  Numbers in each 
quadrant represent percentages of cells.  (C) CD4+ T cells (5x105/well) from mice not infected 
or infected with PbA for 7 days (parasitemia 3.7-5.6 %) were stimulated with plate-coated 
anti-TCR mAb for 0-48 hrs.  The levels of mRNA in uninfected (○) and PbA-infected mice (●) 
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Figure 2 
Correlation between parasitemia levels and production of IFN- by CD4+ T-cells. 
(A) Mice (3 mice/group) were infected with PbA and the level of parasitemia (▲) was 
determined.  CD4+ T cells prepared from each mouse were stimulated with plate coated 
anti-TCR mAb and IFN- levels in the supernatant were determined by ELISA (●).  Values 
shown are the means + SD from each mouse. 
(B) After 7 days of infection (parasitemia 7.4-8.8%), mice were treated daily with chloroquine 
for 6days.  The levels of parasitemia (▲) and IFN- production of CD4+ T cells (●) were 
determined.  Representative data of 2 similar results are shown.   
(C) Naïve (CD62LhighCD44low) and effector/memory (CD62LlowCD44high) CD4+ T cells were 
purified from uninfected (open bar) and infected for 7 days (parasitemia 8.6%)(closed bar) 
B6 mice by cell sorting, and were stimulated on plates coated with anti-TCR mAb.  The 
levels of IFN- in the supernatant were determined by ELISA.  A significant difference in 
the levels of IFN-was observed between uninfected and infected mice for whole and 
effector/memory cells (p < 0.05), while no difference was observed for naïve cells.  Either 
for uninfected or infected mice, the levels of IFN- was significantly higher in whole and 
effector/memory cells than in naïve cells, while no significant difference was observed in 
the levels of IFN- between whole and effector/memory cells.  Representative data of 3 
similar results are shown. 
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Figure 3  
Proliferation and cytokine production of CD4+ T cells in mice after infection with OVA-PbA.   
B6.Ly5.1 (CD45.1+) (A) or B6 (B-D) mice were adoptively transferred with CFSE-labeled 
OT-II (A, CD45.2+, 1x107) or CD45.1 OT-II cells (B-D, 3x107), respectively, and were 
uninfected or infected with WT- or OVA-PbA.   
(A) Seven days later (parasitemia 13.6%-15.0%), spleen cells were analyzed using flow 
cytometry.  The numbers in the right upper corner represent the proportions of OT-II 
(CD45.2+CD4+) cells.   Representative data of 4 similar results are shown.   
(B) Seven days after adoptive transfer of CD45.1 OT-II cells (parasitemia 3.8-4.2%), spleen 
cells were stained with allophycocyanin-anti-CD4, PE-Cy7-anti-CD45.1, PE-anti-CD69, 
FITC-anti-CD25, PE-anti-CD62L and FITC-anti-CD44 mAbs. FACS profiles of OT-II 
(CD45.1+CD4+) and host B6 (CD45.1-CD4+)-gated populations are shown.  The number in 
each quadrant represents the proportion of each population. 
(C)  CD4+ T cells were stimulated with dendritic cells pulsed with OVA323-339.  The proportion 
of OT-II in total CD4+ T cells was 3.7-5.9 %.  The levels of IFN- were significantly higher 
both in WT-PbA-infected mice and in OVA-PbA-infected mice than in uninfected mice (p 
< 0.05).  Representative data of 6 similar results are shown. 
(D) After 8 days of infection (parasitemia 9.0%), CD4+ T cells were purified, stimulated with 
DC pulsed with OVA323-339 for 24h, and the production of IFN- was analyzed by 
intracellular cytokine staining of  CD45.1+CD4+ (OT-II cells, left panels) and 
CD45.2+CD4+ (B6 host cells, right panels) gated populations.  Representative data of 3 
similar results are shown. 
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Figure 4 
Cooperation of CD4+ T cells from PbA-infected mice and OT-II cells in producing IFN-. 
B6 mice were adoptively transferred with CD45.1 Rag-2-/- OT-II cells (1x107) and were 
infected or not infected with OVA-PbA.  After 7 days (parasitemia 6.7%), OT-II and host B6 
CD4+ T cells were purified by cell sorting from uninfected (open bar) and infected (closed bar) 
mice, and were cultured in the presence of DC (1x104) pulsed with OVA323-339. The numbers 
of OT-II (2x104) and host CD4+ T cells (1.8x105) in culture were determined to reflect the 
original in vivo ratio of these cells.  Addition of OT-II cells from uninfected or infected mice 
showed a significantly larger effects in increasing IFN- levels in infected B6 cells than in 
uninfected B6 cells (p < 0.05).  Representative data of 3 similar results are shown. 
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Figure 5 
CD4+ T cells from PbA-infected mice produce IFN- in response to a soluble factor produced 
by OT-II / OVA323-339-pulsed DC. 
(A) CD4+ T cells from uninfected (open bar) or PbA-infected for 8 days (parasitemia 5.8-8.8 %, 
closed bar) mice or no cells (gray bar) were placed in the upper or lower chamber of a Transwell 
plate, and OT-II cells were placed in the lower chamber in the presence and absence of DC 
pulsed with or without OVA323-339.  In the group with OT-II/OVA-DC in lower well, the levels 
of IFN- in CD4+ T cells were significantly higher in those from infected mice than in those 
from uninfected mice irrespective of whether T cells were in upper well or lower well (p < 0.05).  
Representative data of 3 similar results are shown.   
(B) CD4+ T cells from uninfected (open bar) or infected for 6 days (parasitemia 4.0-5.7 %, 
closed bar) mice or no cells (gray bar) were cultured in the presence (OT-II/OVA-DC) and 
absence (-) of OT-II cells and DC pulsed with OVA323-339, or in the presence of supernatant 
from OT-II cells stimulated with OVA323-339-pulsed DC (SUP).  Either in group with 
OT-II/OVA-DC or with OVA-DC, the levels of IFN- were significantly higher in CD4+ T cells 
from infected mice than in those from uninfected mice (p < 0.05).  Representative data of 4 
similar results are shown. 
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Figure 6 
The soluble mediator that stimulates IFN- production of CD4+ T cells from PbA-infected mice 
is not IL-12 or IL-18. 
 (A, B, left) CD4+ T cells from the infected for 7 days (parasitemia 5.2-7.7%) mice were 
cultured in the presence of varying concentrations of recombinant IL-12 or IL-18 with (open 
bar) and without (closed bar) anti-IL-12 mAb or anti-IL-18 mAb, respectively.  In CD4+ T cells 
from the infected mice, IFN- was produced significantly depending on the levels of rIL-12 (p < 
0.05), while the production was blocked by anti-IL-12 mAb.  Although a similar dose-response 
was suggested for rIL-18, the level of IFN- at 1000 (ng/ml) was significantly higher (p < 0.05) 
compared to that at 100 or 0 (ng/ml).  (A, right) CD4+ T-cells from uninfected or infected mice 
were cultured in the presence and absence of supernatant of OT-II /OVA323-339-pulsed DC 
(SUP) with (open bar) and without (closed bar) anti-IL-12 mAb.  In the presence of SUP, no 
significant difference was observed in the levels of IFN- between CD4+ T-cells with or without 
anti-IL-12 mAb.  Representative data of 2 similar results are shown.  (B, right) CD4+ T-cells 
from uninfected or infected B6 or MyD88-/-TRIF-/- double knock-out mice were cultured in the 
presence and absence of SUP with (open bar) and without (closed bar) anti-IL-18 mAb.  In both 
of CD4+ T cells from B6 and DKO mice, the levels of IFN- significantly increased in the 
presence of SUP irrespective of whether the mice were infected or uninfected and of with or 
without anti-IL-18 (p < 0.05).  However, no significant decrease with anti-IL-18 mAb was 
observed in the levels of IFN-.  (C) CD4+ T-cells from uninfected and infected for 7 days 
(parasitemia 7.6%) B6 mice were cultured in the presence (+) and absence (-) of SUP with 
(closed bar) and without (open bar) anti-IL-12, anti-IL-18 mAb or both.  In CD4+ T cells either 
from uninfected or infected mice, the levels of IFN- significantly increased with SUP (p < 
0.05).  However, single or simultaneous effects of anti-IL-12 and anti-IL-18 mAbs in blocking 
the increase were not significant.  Representative data of 2 similar results are shown. 
  32 
Figure 7 
IL-2 stimulates CD4+ T cells from PbA-infected mice to produce IFN-, IL-4 and IL-10.  
(A) CD4+ T cells from infected (8 days, parasitemia 9.8 %, closed bar) and uninfected (open 
bar) mice were stimulated with the supernatant from the OT-II/OVA323-339-pulsed DC (SUP), 
recombinant IL-2 (rIL-2) or co-cultured with OT-II and OVA323-339-pulsed DC 
(OT-II/OVA-DC) in the presence (+) and absence (-) of anti-CD25 mAbs.  In CD4+ T cells from 
PbA-infected mice, addition of SUP, rIL-2 or OT-II/OVA-DC significantly increased the levels 
of IFN-, IL-4 and IL-10 (p < 0.05), and such an increase was significantly blocked by anti- 
CD25 mAbs (p < 0.05).  Representative data of 3 similar results are shown.   
(B) CD4+ T cells from infected (7 days, parasitemia 6.6%, closed bar) and uninfected (open bar) 
mice were cultured in the presence of varying concentrations of recombinant IL-2.  The levels 
of IFN- in the culture supernatant were determined by ELISA.  In CD4+ T cells from infected 
mice, the levels of IFN- significantly increased with IL-2 equal to or exceeding 1.25 ng/ml (p < 
0.05). 
 (C) CD4+ T cells from the infected (7 days, parasitemia 5.2-7.7%) mice were cultured with 
(gray bar) and without (closed bar) anti-CD25 mAbs for 24-48 h.  The proportions of viable 
(Annexin V-7AAD-) cells were determined by staining with Annexin V and 7AAD.  The levels 
of IFN- in the culture supernatant were determined by ELISA.  At each time point, no 
significant difference was observed in the frequency of viable cells between cells with and 
without anti-CD25 mAbs for either with or without rIL-2.  Representative data of 4 similar 
results are shown. 
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Figure 8 
CD4+ T cells from PbA-infected mice express high levels of IL-2 receptor. 
(A) Spleen cells from B6 mice uninfected or infected for 8 days with PbA (parasitemia 
6.7-13.1%) were stained with PE-Cy7-anti-CD4, allophycocyanin-streptavidin plus 
biotin-anti-NK1.1, FITC-anti-TCR and PE-anti-CD25 or PE-anti-CD122 mAbs.  The 
expression of CD25 and CD122 are shown for CD4+NK1.1+TCR+ and CD4+NK1.1-TCR+ 
gated populations.   
(B) Spleen cells from B6 mice uninfected or infected for 7 days with PbA (parasitemia 
4.4-4.9%) were stained with PE-Cy7-anti-CD4, FITC-anti-CD25, FITC-streptavidin plus 
biotin-anti-CD122, and with PE-anti-Foxp3 mAbs, and the profiles of CD4+ gated populations 
are shown (Left).  The number represents the proportion of cells in each region within total 
CD4+ cells from uninfected (open bar) and PbA-infected (closed bar) mice.  The experiments 
were repeated 5 times and the mean ± SD of each subpopulation within CD4+ cells are shown 
(Right).  The proportions of Fox3-CD25+ cells and Fox3-CD122+ cells both significantly 
increased in infected mice than in uninfected mice.  
(C) CD4+ cells from B6 mice infected or uninfected with PbA were stimulated with IL-2 for 24 
hrs, stained with PE-Cy7-anti-CD4, allophycocyanin-streptavidin plus biotin-anti-NK1.1, 
FITC-anti-TCR, and with PE-anti-IFN- mAb. Numbers in the right quadrant represent the 
proportion of IFN- producing cells in total CD4+ cells for CD4+NK1.1+TCR+ and 
CD4+NK1.1-TCR+ gated populations (Left).  Representative data of 4 similar results are shown.  
The number of IFN- producing cells in each spleen was calculated from 4 mice in each group 
(Right).  The number of IFN- producing cells was significantly larger in CD4+NK1.1-TCR+ 
gated population than in CD4+NK1.1+TCR+ gated population (p < 0.001). 
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Figure 9 
IFN- production of CD4+ T cells from PbA-infected mice in response to malaria antigen is 
IL-2-dependent. 
CD4+NK1.1- T cells from mice uninfected or infected for 7 days (parasitemia 10.6 %) were 
cultured in the absence (-) and presence of IL-2 (rIL-2), DC (DC), DC pulsed with soluble 
malaria antigen (PbA/DC) or anti-TCR mAb (TCR) with (open bar) and without (closed bar) 
anti-CD25 mAbs (A).  In T cells from uninfected mice, the level of IFN- was significantly 
lower for PbA/DC and anti-TCR mAb in those with anti-CD25 mAbs than in those without 
anti-CD25 mAbs (p < 0.05).  On the other hand, in T cells from infected mice, although the 
level of IFN- was significantly lower for rIL-2 and PbA/DC in those with anti-CD25 mAbs 
than in those without anti-CD25 mAbs (p < 0.05), no such significant difference was observed 





A model of the production of IFN-, IL-4 and IL-10 by CD4+ T cells from PbA-infected mice.  
CD4+ T cells from B6 mice that were transferred with OT-II cells and were infected with PbA 
produced IFN-, IL-4 and IL-10 in response to DC pulsed with OVA in vitro. 
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Figure 9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10 
 
